This webinar is second in the series discussing, Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies.
© 2024 Rutgers, The State University of New Jersey. All rights reserved.
225 Warren Street, Newark, New Jersey 07103
973-972-3270
globaltbinstitute@njms.rutgers.edu
